Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.27
Delayed Data
As of May 22
 -0.02 / -0.87%
Today’s Change
1.85
Today|||52-Week Range
4.97
-14.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization169.0K167.0K169.0K--
 
 
 
 
 
Operating ExpensesGross Income-169.0K-167.0K-169.0K0.00
 
 
 
 
General Expenses21.5M19.3M19.7M20.3M
 
 
 
 
 
Research And Development18.8M16.2M15.7M16.2M
 
 
 
 
 
Total Operating Expenses21.7M19.4M19.9M20.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.7M-19.4M-19.9M-20.3M
 
 
 
 
 
Interest Expense On Debt585.0K517.0K458.0K375.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.3M-20.0M-20.4M-20.7M
 
 
 
 
 
Net Income-22.3M-20.0M-20.4M-20.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS94.0M105.8M108.4M108.4M
 
 
 
 
 
Shares To Calculate EPS Diluted94.0M105.8M108.4M108.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.24-$0.19-$0.19-$0.19
 
 
 
 
 
EPS Diluted-$0.24-$0.19-$0.19-$0.19
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account